We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Customized Isotopes Hold Promise for Advances in Science

By Biotechdaily staff writers
Posted on 05 Jun 2008
A promising future in nuclear physics is in the design of isotopes--the ability scientists have to construct specific rare isotopes to solve scientific problems and create avenues to new technologies, according to investigators.

"We have developed a remarkable capability over the last 10 or so years that allows us to build a specific isotope to use in research,” said Dr. More...
Bradley Sherrill, a professor of physics and associate director for research at the National Superconducting Cyclotron Laboratory (NSCL) at Michigan State University (MSU; East Lansing, USA). "It is a new tool that promises to allow whole new directions in research to move forward. There are tremendous advances that are possible.”

Dr. Sherrill described some of the possibilities, and what it will take to get there, in an article in the May 9, 2008, issue of Science magazine. In that article, he reported that nanotechnology is getting a lot of attention for the amazing possibilities of building objects with individual atoms and molecules. Developments in basic nuclear science already have given way to technologies such as PET scans--medical procedures that use special isotopes to target specific types of tumors.

Isotopes are the different versions of an element. Their nuclei have different numbers of neutrons, and thus give them different characteristics. Rare isotopes do not always exist in nature--they must be enticed out with high-energy collisions created by special machines, like those in MSU's Coupled Cyclotron facility. As technology advances, newer equipment is needed.

The next step for the U.S. nuclear science community will be the Facility for Rare Isotope Beams, a world-leading facility for the study of nuclear structure and nuclear astrophysics, expected to be built by the U.S. Department of Energy sometime in the next decade.

According to Dr. Sherrill, this type of basic science--science to evaluate the core nature of the elements of life--has a lot of potential. He offers up positron emission tomography (PET) scans--as an example of the payoff associated with pushing the bounds of accelerator science to assess new specific isotopes. To create PET scans, scientists first had to create an isotope with a specific radioactivity that decayed quickly enough and safely enough to inject in the body.

"The rare-isotope research supported by National Science Foundation at the NSCL enables us to push forward our understanding of nuclei at the frontiers of stability, with direct connections to the processes that produce the elements in our world and that underlie the life cycle of stars,” said Bradley Keister, a program officer in NSF Physics Division. "Applications to societal areas including medicine and security have traditionally gone hand in hand with these ever-advancing capabilities.”

In the Science article, Dr. Sherrill stated that aggressively pursuing rare isotope research is necessary. "These are isotopes that are not easy to produce. That's the frontier we're working on, Dr. Sherrill wrote in his article. "A wider range of available isotopes should benefit the fields of biomedicine [by producing an expanded portfolio of radioisotopes], international security [by providing the technical underpinning to nuclear forensics specialists], and nuclear energy [by leading to better understanding of the sort of nuclear reactions that will power cleaner, next-generation reactors].”


Related Links:
National Superconducting Cyclotron Laboratory at Michigan State University

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.